Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for MESO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2023 167.58M
March 31, 2023 168.27M
December 31, 2022 168.06M
September 30, 2022 161.69M
June 30, 2022 253.34M
March 31, 2022 164.56M
December 31, 2021 168.93M
September 30, 2021 162.07M
June 30, 2021 243.48M
March 31, 2021 165.20M
December 31, 2020 248.70M
September 30, 2020 174.07M
June 30, 2020 263.37M
March 31, 2020 177.98M
December 31, 2019 262.29M
September 30, 2019 246.09M
Date Value
June 30, 2019 236.49M
March 31, 2019 174.76M
December 31, 2018 223.88M
September 30, 2018 218.45M
June 30, 2018 203.01M
March 31, 2018 177.30M
December 31, 2017 142.13M
September 30, 2017 193.40M
June 30, 2017 217.15M
March 31, 2017 213.10M
December 31, 2016 150.36M
September 30, 2016 223.70M
June 30, 2016 220.88M
March 31, 2016 291.21M
December 31, 2015 298.20M
September 30, 2015 300.04M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Immutep Ltd. --
CSL Ltd. --
Ceryvyn Therapeutics Ltd. --
Propanc Biopharma, Inc. 4.506M
Actinogen Medical Ltd. --